126 related articles for article (PubMed ID: 12188324)
1. Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights.
Roberts TP; Turetschek K; Preda A; Novikov V; Moeglich M; Shames DM; Brasch RC; Weinmann HJ
Acad Radiol; 2002 Aug; 9 Suppl 2():S511-3. PubMed ID: 12188324
[No Abstract] [Full Text] [Related]
2. MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model.
Turetschek K; Preda A; Floyd E; Shames DM; Novikov V; Roberts TP; Wood JM; Fu Y; Carter WO; Brasch RC
Acad Radiol; 2002 Aug; 9 Suppl 2():S519-20. PubMed ID: 12188326
[No Abstract] [Full Text] [Related]
3. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
[TBL] [Abstract][Full Text] [Related]
4. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
Olaso E; Vidal-Vanaclocha F
Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
[No Abstract] [Full Text] [Related]
5. Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?
Brasch RC; Gossmann A; Helbich TH; Kuriyama N; Roberts TP; Shames DM; van Bruggen N; Wendland MF; Israel MA
Acad Radiol; 2002 Aug; 9 Suppl 2():S326-7. PubMed ID: 12188263
[No Abstract] [Full Text] [Related]
6. Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors.
Turetschek K; Huber S; Helbich T; Floyd E; Tarlo KS; Roberts TP; Shames DM; Wendland MF; Brasch RC
Acad Radiol; 2002 May; 9 Suppl 1():S112-4. PubMed ID: 12019843
[No Abstract] [Full Text] [Related]
7. Assessing perfusion and capillary permeability changes induced by a VEGF inhibitor in human tumor xenografts using macromolecular MR imaging contrast media.
Clément O; Pradel C; Siauve N; Frouin F; Bruneteau G; Kahn E; Frija G; Cuénod CA
Acad Radiol; 2002 Aug; 9 Suppl 2():S328-9. PubMed ID: 12188264
[No Abstract] [Full Text] [Related]
8. High resolution MRI of MCF7 human breast tumors: complemented use of iron oxide microspheres and Gd-DTPA.
Furman-Haran E; Margalit R; Grobgeld D; Degani H
J Magn Reson Imaging; 1998; 8(3):634-41. PubMed ID: 9626879
[TBL] [Abstract][Full Text] [Related]
9. Tipping the balance for angiogenic disorders.
Gao G; Ma J
Drug Discov Today; 2002 Feb; 7(3):171-2. PubMed ID: 11815230
[No Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI.
Leenders W; Küsters B; Pikkemaat J; Wesseling P; Ruiter D; Heerschap A; Barentsz J; de Waal RM
Int J Cancer; 2003 Jul; 105(4):437-43. PubMed ID: 12712432
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
Claes A; Gambarota G; Hamans B; van Tellingen O; Wesseling P; Maass C; Heerschap A; Leenders W
Int J Cancer; 2008 May; 122(9):1981-6. PubMed ID: 18081012
[TBL] [Abstract][Full Text] [Related]
12. Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience.
Daldrup-Link HE; Kaiser A; Link TM; Settles M; Helbich T; Werner M; Roberts TP; Rummeny EJ
Acad Radiol; 2002 Aug; 9 Suppl 2():S343-7. PubMed ID: 12188270
[No Abstract] [Full Text] [Related]
13. Basic physics of MR contrast agents and maximization of image contrast.
Hendrick RE; Haacke EM
J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
[TBL] [Abstract][Full Text] [Related]
14. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
[TBL] [Abstract][Full Text] [Related]
15. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent.
Karczmar GS; Fan X; Al-Hallaq H; River JN; Tarlo K; Kellar KE; Zamora M; Rinker-Schaeffer C; Lipton MJ
Acad Radiol; 2002 May; 9 Suppl 1():S115-8. PubMed ID: 12019844
[No Abstract] [Full Text] [Related]
16. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
[TBL] [Abstract][Full Text] [Related]
18. The potential value of iron oxide nanoparticles in brain tumor treatment.
Gutin PH
AJNR Am J Neuroradiol; 2002 Apr; 23(4):505. PubMed ID: 11950633
[No Abstract] [Full Text] [Related]
19. Quantitative assessment of the contrast behavior of typical focal hepatic lesions before and after the administration of Gd-DTPA and superparamagnetic iron oxide particles.
Helmberger T; Holzknecht N; Reiser M
Acad Radiol; 2002 Aug; 9 Suppl 2():S468-72. PubMed ID: 12188311
[No Abstract] [Full Text] [Related]
20. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
Gambarota G; Leenders W; Maass C; Wesseling P; van der Kogel B; van Tellingen O; Heerschap A
Br J Cancer; 2008 Jun; 98(11):1784-9. PubMed ID: 18506183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
